#Antibody

Queen Elizabeth Prize for Engineering

QEPrize

Hello everyone! I'm Esther Odekunle (@EstOdek) and today I'll be tweeting from @QEPrize to take you on a journey of what being an antibody engineer is all about. Hold on

ʀ⎊ᴜ ʀᴇʏɴ⎊

RouReynolds

As our grandparents, parents, & friends get vaccinated, I thought I’d just relay info on getting the most out of your vaccination, as simple behaviour changes may support how well

Ryan McNamara 🧬

Ryan_Mac_Phd

Viruses change over time, particularly when acclimating to a new host. Variants increase as prevalence increases. The Great Barrington Clowns proposed letting the virus run rampant through young adults as

Dr. Lynora Saxinger 🇨🇦

AntibioticDoc

A thread about COVID19 mRNA vaccine second dose timing controversies:Basically I think it’s honestly a good move to have a flexible (out to 6 week) second dose (and was lobbying

Prof Francois Balloux

BallouxFrancois

Over the last weeks, a substantial amount of new evidence has become available about immunity to #SARSCoV2. This information can be difficult to process and integrate. As such I felt

David Boulware, MD MPH

boulware_dr

Important finding that 50mcg @moderna_tx vaccine dose (1/2 dose) generated the same #SARSCoV2 antibody response as the regular dose. This would double vaccine supply. This important finding will no doubt

Björn Meyer

_b_meyer

Seeing that B1.1.7 now acquired the E484K mutation in the UK, could we, at least for now, stop the narrative that this double mutation occurs by high immune pressure, please?because

Apoorva Mandavilli

apoorva_nyc

You know people -- maybe you're one of them -- who were sick with Covid, but tested negative for antibodies. Why would that be? Blame the tests. They miss antibodies

Rebekah Jones

GeoRebekah

Having some issues with the site while ESRI does "system maintenance," but trying to get everything updated now. +7,023 new cases (1.79 million total)+238 new deaths (28,526 per @HealthyFla; 33,697

IndiaSpend

IndiaSpend

New research has shown that pre-existing antibodies for the common cold could help protect people, especially children, from #COVID19. Read this thread for insights: Scientists at the University College London

Silas Savant

SiIasSavant

Well looky here.... who's been behind the fraudulent C-19 numbers, from anti-bodies to everything else?Give me a D.Give me an O.Give me an M.Give me an I.Give me an N.Give

Eric Meyerowitz, MD

EricMeyerowitz

1/ Key question right now is how much SARS-CoV-2 vaccines will decrease transmission.Data from Regeneron mAb cocktail prevention press release may help us think about thishttps://investor.regeneron.com/news-releases/news-release-details/reg

UK-CIC

UKCICstudy

1/ We’re pleased to contribute to this new @SciImmunology paper showing both T cell & antibody responses are important in #COVID19 immunity at 4 months post mild/asymptomatic infection @Imperialcollege @ucl

Justin Schecker

WFLAJustin

Three ways the medical community is better at fighting COVID-19 now vs. early in the pandemic (just in case someone tells you to watch the Breitbart doctors press conference): 1)

Craig Wilen

WilenLab

Excited to share our new paper led by @chennifer_jen looking at the role of NSAIDs in #COVID19. NSAIDs dampen the cytokine and antibody response to SARS-CoV-2 infection @ASMicrobiology @JVirology @Yale_LabMed

Hensley Lab

SCOTTeHENSLEY

There has been recent discussion of how this influenza virus mouse study that I completed as a postdoc potentially relates to current SARS-CoV-2 evolution, so I thought I would write

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.